ABBV vs DGX
By Alex · Tickerpine
AbbVie Inc. vs Quest Diagnostics Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | DGX |
|---|---|---|
| Price | $253.35 | $209.88 |
| Market cap | $447.62B | $23.23B |
| P/E ratio | 123.6 | 23.2 |
| ROE | — | 14.54% |
| Profit margin | 5.79% | 9.08% |
| Revenue growth | 12.40% | 9.20% |
| Dividend yield | 2.73% | 1.64% |
| Beta | 0.31 | 0.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs DGX in plain English
- ABBV is the bigger company — about 19.3× the market cap of DGX.
- DGX is cheaper on earnings (P/E 23.2 vs 123.6).
- ABBV is growing revenue faster (12% vs 9%).
- ABBV has the higher dividend yield (2.73% vs 1.64%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
DGX return calculator
See what $1,000 in Quest Diagnostics Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.